OBSIDIAN THERAPEUTICS Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 86897200. The federal status of this trademark filing is REGISTERED as of Tuesday, August 14, 2018. This trademark is owned by Obsidian Therapeutics. The OBSIDIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the field of gene therapy for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders
obsidian therapeutics

General Information

Serial Number86897200
Word MarkOBSIDIAN THERAPEUTICS
Filing DateThursday, February 4, 2016
Status700 - REGISTERED
Status DateTuesday, August 14, 2018
Registration Number5541432
Registration DateTuesday, August 14, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations in the field of gene therapy for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code005
First Use Anywhere DateThursday, June 7, 2018
First Use In Commerce DateWednesday, June 7, 2017

Trademark Owner History

Party NameObsidian Therapeutics
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, February 15, 2024TEAS SECTION 7 REQUEST RECEIVED
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 10, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 9, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 14, 2018USE AMENDMENT FILED
Monday, July 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 14, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, February 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2018SOU EXTENSION 3 GRANTED
Monday, February 26, 2018SOU EXTENSION 3 FILED
Monday, February 26, 2018SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2017SOU EXTENSION 2 GRANTED
Wednesday, September 6, 2017SOU EXTENSION 2 FILED
Wednesday, September 6, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2017SOU EXTENSION 1 GRANTED
Tuesday, February 14, 2017SOU EXTENSION 1 FILED
Tuesday, February 14, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 6, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, May 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NON-FINAL ACTION WRITTEN
Friday, May 20, 2016ASSIGNED TO EXAMINER
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 8, 2016NEW APPLICATION ENTERED

Related Keywords

therapeutics obsidian disorders system musculo metabolic immune skeletal nervous gastroenterological inflammatory respiratory